Artículos por temáticas

Semaglutide and the pathogenesis of progressive neurodegenerative disease: the central role of mitochondria

Stefano GB, Büttiker P, Weissenberger S, Raboch J, Anders M.

Front Neuroendocrinol. 2025 Oct 3:101217. doi: 10.1016/j.yfrne.2025.101217. Online ahead of print.

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease"

Muñoz-Delgado L, Williams-Gray CH, Garraux G, Clemente D, Çakmak ÖÖ, Greenland JC, Figueira I, Machín-Díaz I, Pirovano E, di Flora A, Tournerie C, Papoutsopoulou S, Ertan S, Mir P, Comi C.

NPJ Parkinsons Dis. 2025 Oct 20;11(1):299. doi: 10.1038/s41531-025-01146-1.

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease

Alborghetti M, Ceccherelli A, Caridi M, Nicoletti F, Battaglia G, Bruno V.

NPJ Parkinsons Dis. 2025 Oct 10;11(1):290. doi: 10.1038/s41531-025-01138-1.

DJ-1 in Parkinson's disease: Its important role at endoplasmic reticulum-mitochondria contact sites

Fan H, Li Y, Huang J, Jiang J, Feng F, Huang N, Luo Y.

Behav Brain Res. 2025 Oct 18;495:115775. doi: 10.1016/j.bbr.2025.115775. Epub 2025 Aug 12.

Validation of Genome-Wide Association Study (GWAS)-Identified Risk Loci for Parkinson's Disease in the Chinese Population

Li C, Ou R, Hou Y, Wei Q, Zhang L, Lin J, Liu K, Huang J, Chen X, Song W, Zhao B, Wu Y, Shang H.

Mov Disord. 2025 Oct;40(10):2272-2274. doi: 10.1002/mds.30291. Epub 2025 Jul 3.

The role of L-DOPA in neurological and neurodegenerative complications: a review

Kulkarni SR, Thokchom B, Abbigeri MB, Bhavi SM, Singh SR, Metri N, Yarajarla RB.

Mol Cell Biochem. 2025 Oct;480(10):5221-5242. doi: 10.1007/s11010-025-05324-w. Epub 2025 Jun 9.

Functional training and Mat Pilates have a positive effect on non-motor symptoms improving cognition, depressive symptoms, anxiety, and happiness in people with Parkinson's disease: a randomized controlled clinical trial with follow-up

Moratelli JA, Corrêa CL, Andrade A, Lyra VB, Guimarães ACA.

Aging Ment Health. 2025 Oct;29(10):1892-1901. doi: 10.1080/13607863.2025.2496728. Epub 2025 Apr 28.

Physical exercise and inflammation in Parkinson's disease: a review

Han C, Zhang H, Wang Q, Meng P, Hou Y, Zhang Y.

Neurol Sci. 2025 Oct 14. doi: 10.1007/s10072-025-08548-2. Online ahead of print.

Therapeutic modulation of cGAS-STING pathway in neurodegeneration

Sharma V, Verma R, Sharma P, Singh TG.

Brain Res. 2025 Oct 1;1864:149784. doi: 10.1016/j.brainres.2025.149784. Epub 2025 Jun 13.

Management of Anxiety in Parkinson's Disease

Berry AJ, Costello H, Jesús S, Price G, Jha A.

Mov Disord Clin Pract. 2025 Oct;12(10):1490-1501. doi: 10.1002/mdc3.70144. Epub 2025 Jun 26.

From adaptive deep brain stimulation to adaptive circuit targeting

Horn A, Neumann WJ.

Nat Rev Neurol. 2025 Oct;21(10):556-566. doi: 10.1038/s41582-025-01131-5. Epub 2025 Sep 3.

The senescent synapse: A look at autophagy, calcium handling, and mitochondrial bioenergetics at the synapse in ageing and Parkinson's disease

Mukhtar S, Kataria S, Cimaglia G, Beccano-Kelly D.

Curr Res Physiol. 2025 Oct 9;8:100166. doi: 10.1016/j.crphys.2025.100166. eCollection 2025.

Association between gout, hyperuricemia, and Parkinson's disease: a systematic review and meta-analysis

Qtaishat FA, Alsufi MI, Yasin JA, Abunamoos A, Salomon I, Qutaishat S, Odat RM.

Eur J Med Res. 2025 Sep 29;30(1):904. doi: 10.1186/s40001-025-03202-1.

Epigenetic mechanisms linking environmental exposure to Parkinson's disease: A comprehensive review

Singh H, Kumari S, Taliyan R.

Neuroscience. 2025 Oct 15;585:367-380. doi: 10.1016/j.neuroscience.2025.08.060. Epub 2025 Sep 11.

Parkinson's disease - The dentist's role as part of the healthcare team

Camacho LO, Jahangiri L, Iseringhausen J, Goldstein GR.

J Prosthodont. 2025 Oct;34(8):796-803. doi: 10.1111/jopr.13862. Epub 2024 Apr 30.